Boston Scientific Corporation Stock
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.73 USD | +0.82% |
|
-2.02% | -21.63% |
| 07/02 | Markets Ask the Obvious Question | |
| 06/02 | Analyst recommendations: Crown Holdings, Meta Platforms, Roku, Alphabet, Qualcomm… |
| Capitalization | 111B 93.38B 85.17B 81.32B 151B 10,038B 157B 991B 393B 4,847B 416B 407B 16,942B | P/E ratio 2025 |
49.1x | P/E ratio 2026 * | 30.1x |
|---|---|---|---|---|---|
| Enterprise value | 120B 101B 91.96B 87.79B 163B 10,837B 169B 1,070B 425B 5,234B 449B 440B 18,292B | EV / Sales 2025 |
7.04x | EV / Sales 2026 * | 5.23x |
| Free-Float |
84.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +0.82% | ||
| 1 week | -2.02% | ||
| Current month | -20.10% | ||
| 1 month | -20.28% | ||
| 3 months | -27.23% | ||
| 6 months | -28.25% | ||
| Current year | -21.63% |
| 1 week | 72.69 | 76.37 | |
| 1 month | 72.69 | 94.75 | |
| Current year | 72.69 | 100.9 | |
| 1 year | 72.69 | 109.5 | |
| 3 years | 45.92 | 109.5 | |
| 5 years | 34.98 | 109.5 | |
| 10 years | 16.62 | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
John Sorenson
COO | Chief Operating Officer | 58 | 01/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
John Sununu
BRD | Director/Board Member | 61 | 01/04/2009 |
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.82% | -2.02% | -29.57% | +58.06% | 111B | ||
| -0.98% | -7.00% | -5.08% | -11.66% | 190B | ||
| +1.51% | -0.47% | -18.42% | +101.52% | 173B | ||
| -1.10% | -1.86% | +3.04% | -17.04% | 150B | ||
| +0.79% | -1.74% | -29.86% | -20.76% | 53.87B | ||
| -0.75% | -3.61% | -0.42% | -0.94% | 44.03B | ||
| +2.78% | -7.02% | +8.40% | +18.06% | 36.79B | ||
| +2.15% | -0.38% | -12.87% | +10.65% | 36.61B | ||
| +0.74% | -2.91% | -6.58% | -17.79% | 35.58B | ||
| -1.19% | -1.96% | -25.99% | -42.05% | 32.52B | ||
| Average | +0.48% | -2.49% | -11.74% | +7.80% | 86.27B | |
| Weighted average by Cap. | +0.21% | -2.46% | -11.40% | +19.79% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 20.07B 16.91B 15.43B 14.73B 27.34B 1,818B 28.4B 179B 71.23B 878B 75.28B 73.73B 3,068B | 22.29B 18.78B 17.13B 16.36B 30.36B 2,019B 31.54B 199B 79.1B 975B 83.6B 81.88B 3,408B |
| Net income | 3.01B 2.54B 2.31B 2.21B 4.1B 273B 4.26B 26.92B 10.69B 132B 11.29B 11.06B 460B | 3.66B 3.09B 2.82B 2.69B 4.99B 332B 5.18B 32.75B 13B 160B 13.74B 13.46B 560B |
| Net Debt | 8.83B 7.44B 6.79B 6.48B 12.02B 800B 12.49B 78.92B 31.33B 386B 33.11B 32.43B 1,350B | 5.7B 4.8B 4.38B 4.18B 7.76B 516B 8.06B 50.93B 20.22B 249B 21.37B 20.93B 871B |
Employees
53,000
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/02/26 | 74.73 $ | +0.82% | 13,452,417 |
| 12/02/26 | 74.12 $ | +0.88% | 16,871,948 |
| 11/02/26 | 73.47 $ | -1.05% | 20,102,918 |
| 10/02/26 | 74.25 $ | +0.18% | 21,080,942 |
| 09/02/26 | 74.12 $ | -2.82% | 21,133,732 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
34
Last Close Price
74.73USD
Average target price
105.41USD
Spread / Average Target
+41.05%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition


















